Objective: To determine the thoroughness of terminal disinfection and cleaning of patient rooms in hospital intensive care units and to assess the value of a structured intervention program to improve the quality of cleaning as a means of reducing environmental transmission of multidrug-resistant organisms within the intensive care unit.
Design: Prospective, multicenter, and pre- and postinterventional study.
Setting: Intensive care unit rooms in 27 acute care hospitals. Hospitals ranged in size from 25 beds to 709 beds (mean, 206 beds).
Interventions: A fluorescent targeting method was used to objectively evaluate the thoroughness of terminal room cleaning before and after structured educational, procedural, and administrative interventions. Systematic covert monitoring was performed by infection control personnel to assure accuracy and lack of bias.
Measurements and Main Results: In total, 3532 environmental surfaces (14 standardized objects) were assessed after terminal cleaning in 260 intensive care unit rooms. Only 49.5% (1748) of surfaces were cleaned at baseline (95% confidence interval, 42% to 57%). Thoroughness of cleaning at baseline did not correlate with hospital size, patient volume, case mix index, geographic location, or teaching status. After intervention and multiple cycles of objective performance feedback to environmental services staff, thoroughness of cleaning improved to 82% (95% confidence interval, 78% to 86%).
Conclusions: Significant improvements in intensive care unit room cleaning can be achieved in most hospitals by using a structured approach that incorporates a simple, highly objective surface targeting method and repeated performance feedback to environmental services personnel. Given the documented environmental transmission of a wide range of multidrug-resistant pathogens, our findings identify a substantial opportunity to enhance patient safety by improving the thoroughness of intensive care unit environmental hygiene.
From the Department of Medicine (PCC), Boston University School of Medicine, Boston, MA; Department of Medicine (MFP), Columbia University College of Physicians and Surgeons, New York, NY; Department of Medicine (LABM), Harvard University School of Medicine, Boston, MA; CIC PromedicaHealth (BD), Toledo, OH.
Patents pending for Dr. Carling for the evaluation system (PCC).
The authors have not disclosed any potential conflicts of interest.
For information regarding this article, E-mail: email@example.com